Quintrio
Home

PHARMACEUTICAL PREPARATIONS

Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

Last trade $0.2401
Day change +$0.0207 (+9.43%)
Day range $0.203 – $0.266
Volume 1,817,383
Market cap $1M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for LABT.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for LABT, quarterly periods
Line itemQ2 FY2026 Jun 30, 2026
Revenue$0
Cost of revenue$0
Gross profit$0
Selling, general and administrative$3.29M
Research and development$503.02K
Total operating expenses$3.79M
Operating income-$3.79M
Interest expense-$10.63K
Income before taxes-$3.77M
Income taxes$0
Net income-$3.77M
Net income attributable to common shareholders-$3.9M
EBITDA-$3.79M
Basic earnings per share-$2.75
Diluted earnings per share-$2.75

Recent news

Company coverage with links to the original publishers.

Publication times in UTC

No recent company news found.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Jun 22, 20261-for-10reverse split